½ÃÀ庸°í¼­
»óǰÄÚµå
1514978

¼¼°èÀÇ ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå : À¯Çüº°, Áø´Üº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¿¹Ãø(2024-2032³â)

Virology Testing Market, By Type, By Diagnosis, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 266 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå ±Ô¸ð´Â 2023³â 129¾ï 10¸¸ ´Þ·¯·Î 2024-2032³â¿¡ °ÉÃÄ CAGR 2.90%·Î È®´ë

¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå - ½ÃÀå ¿ªÇÐ

¹ÙÀÌ·¯½º °¨¿°ÀÇ ¸¸¿¬°ú °³ÀÎÈ­ ÀǾàǰ Áõ°¡°¡ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÒ Àü¸Á

¹ÙÀÌ·¯½º¼º ÁúȯÀÇ ºó¹ß°ú È®»êÀº ¹ÙÀÌ·¯½º °Ë»ç ¼ö¿ä¸¦ ÃËÁøÇÕ´Ï´Ù. ÀÎÇ÷翣ÀÚ, HIV, °£¿°, ÁöÄ« ¹× ¿¡º¼¶ó ÃâÇ÷¿­°ú °°Àº ½ÅÈï ¹ÙÀÌ·¯½º¿Í °°Àº Áúº´ÀÇ ¹ß»ýÀº ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÕ´Ï´Ù. ¹ÙÀÌ·¯½º¼º Áúȯ¿¡ ´ëÇÑ ÀǽÄÀÇ ³ô¾ÆÁü°ú Á¶±â ¹ß°ß¡¤Áø´ÜÀÇ Á߿伺ÀÌ, ½ºÅ©¸®´× °Ë»ç¸¦ ¹Þ´Â °ÍÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. °øÁß º¸°Ç Ȱµ¿, ¿¹¹æ Á¢Á¾ Ä·ÆäÀÎ ¹× Á¤±âÀû ÀÎ ½ºÅ©¸®´× ÇÁ·Î±×·¥µµ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÕ´Ï´Ù. Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç, PCR, Â÷¼¼´ë ½ÃÄö½Ì°ú °°Àº ÃֽйÙÀÌ·¯½º °Ë»ç ¹æ¹ýÀº °¨µµ, ƯÀ̼º ¹× Áø´Ü ¼Óµµ¸¦ Çâ»ó½Ãŵ´Ï´Ù. ½ÃÀå È®´ë´Â µ¥ÀÌÅÍ ºÐ¼®, ÀÚµ¿È­ ¹× ºÐ¼® °³¹ßÀÇ Áö¼ÓÀûÀÎ Çõ½ÅÀ¸·Î ´õ¿í ÃËÁøµË´Ï´Ù.

¹ÙÀÌ·¯½º ÇÐÀû °Ë»ç¿Í °°Àº ºÐÀÚÁø´ÜÀÇ Çʿ伺Àº µ¶ÀÚÀûÀÎ ¹ÙÀÌ·¯½º ¹× À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏÀ» ±â¹ÝÀ¸·Î Ä¡·á¹ýÀ» »ç¿ëÀÚ Á¤ÀÇÇÏ´Â °ÍÀ» ¸ñÇ¥·ÎÇÏ´Â ¸ÂÃãÇü ÀÇ·á ¹× ÇÁ¸®½ÃÀü ÀÇ·áÀÇ µ¿Çâ¿¡ ¹Ð·Á ÀÖ½À´Ï´Ù. COVID-19 ÆÒµ¥¹Í°ú °°Àº »ç°Ç¿¡¼­ ÀÔÁõµÈ ¹Ù¿Í °°ÀÌ, °­·ÂÇÑ ¹ÙÀÌ·¯½ºÇÐÀû °Ë»ç ÀÎÇÁ¶ó´Â »õ·Î¿î °¨¿°ÀÇ Á¶±â Áø´Ü, ¸ð´ÏÅ͸µ ¹× ºÀ¼â¿¡ ÇʼöÀûÀÔ´Ï´Ù. À¯Çà¿¡ ´ëÇÑ ´ëºñ¿Í ´ëÀÀÀ» °³¼±Çϱâ À§ÇØ Á¤ºÎ¿Í ÀÇ·á ±â°üÀº ¹ÙÀÌ·¯½º ÇÐÀû °Ë»ç ´É·Â¿¡ ´ëÇÑ ÅõÀÚ¿¡ ³ôÀº ¿ì¼± ¼øÀ§¸¦µÎ°í ÀÖ½À´Ï´Ù.

¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â)¿¡ ¾à 2.90%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À¯Çüº°·Î Àåºñ ºÎ¹®Àº ¼ÒÇü Àåºñ ¹× °ü·Ã ŰƮ¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä·Î ÀÎÇØ 2023³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸¿©ÁÙ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Áø´Üº°·Î´Â PCR¹ýÀÌ ¹ÙÀÌ·¯½º³ª º´¿øÃ¼ÀÇ °ËÃâ¿¡ ³Î¸® »ç¿ëµÇ°í Àֱ⠶§¹®¿¡ 2023³â¿¡´Â PCR¹ý ºÎ¹®ÀÌ ÁÖ¿ä Áø´Ü ºÎ¹®ÀÌ µÇ¾ú½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®ÀÌ 2023³â ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀÚ¿´½À´Ï´Ù.

Áö¿ªº°·Î ºÏ¹Ì°¡ ÀÇ·á»ê¾÷¿¡ ´ëÇÑ ÁöÃâÀÌ ¸¹±â ¶§¹®¿¡ 2023³â¿¡ ¼öÀÍÀ» °¡Á®¿À´Â ÁÖ¿ä ½ÃÀåÀ̾ú½À´Ï´Ù.

¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°èÀÇ ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀåÀº À¯Çü, Áø´Ü, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ±¸ºÐµË´Ï´Ù.

À¯Çüº°·Î´Â Àåºñ, ºÐ¼® ŰƮ, ¼Ò¸ðǰÀÇ ¼¼ °¡Áö·Î ºÐ·ùµË´Ï´Ù. Àåºñ ºÎ¹®ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ±â±â¸¦ ÀÌ¿ëÇÑ Ç׿ø °Ë»ç³ª ¹ÙÀÌ·¯½º °Ë»ç¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä°¡ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº Áø´Ü¹ý¿¡ ÀÇÇØ 5°¡Áö Ä«Å×°í¸®·Î ºÐ·ùµË´Ï´Ù, PCR¹ý, ºÐÀÚÁø´Ü¹ý, Áú·®ºÐ¼®¹ý, ¸é¿ªÃøÁ¤¹ý, ±âŸ. ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ´Â °ÍÀº PCR¹ýÀÔ´Ï´Ù. ÃÖ±Ù COVID-19 ÆÒµ¥¹Íº´ ¹× È£Èí±â ÁúȯÀº PCR ¹æ¹ý ºÎ¹®¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ »ç¿ëÀÚº°·Î º´¿ø ¹× Ŭ¸®´Ð, Áø´Ü½Ç, ±âŸ 3°¡Áö·Î ºÐ·ùµË´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®Àº ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ³ôÀº ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áø´Ü ½ÇÇè½Ç ºÎ¹®Àº ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå·ü·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå - Áö¸®Àû ÅëÂû

¹ÙÀÌ·¯½º °Ë»ç ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ÆÛÁ® ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¼¼°è ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ³ôÀº ÀÇ·á ÁöÃâ, °í±Þ ÀÇ·á ÀÎÇÁ¶ó, °­·ÂÇÑ R&D ´É·Â µîÀÇ ¿äÀÎÀ¸·Î ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áºñ Áõ°¡, ¹ÙÀÌ·¯½º¼º Áúº´ À¯Çà Áõ°¡, ÀÇ·á¼­ºñ½º Á¢±Ù¼º °³¼± µîÀÇ ¿äÀÎÀ¸·Î ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä °³¹ß¿¡´Â Áø´Ü °Ë»ç ½Ã¼³ÀÇ È®´ë¿Í ½Å¼Ó °Ë»ç ±â¼úÀÇ Ã¤¿ë µîÀÌ ÀÖ½À´Ï´Ù.

¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå - °æÀï ±¸µµ:

¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå¿¡´Â ´Ù±¹Àû ±â¾÷°ú ±¹³» ±â¾÷, Á¦³×¸¯ ÀǾàǰ Á¦Á¶¾÷ü, ±â¼ú ÀǾàǰ °³¹ß ±â¾÷ÀÌ È¥ÀçÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ±â¾÷Àº ÆÄÆ®³Ê½Ê Çü¼º, M&A, R&D¿¡ ÅõÀÚÇÏ°í »õ·Î¿î °Ë»ç ±â¼úÀ» Çõ½ÅÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î AbbotÀº HIV, °£¿°, ÀÎÇ÷翣ÀÚ¿Í °°Àº ¹ÙÀÌ·¯½º¿¡ ´ëÇÑ ºÐÀÚ ¹× Ç׿ø ±â¹Ý °Ë»ç¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù. AbbotÀº ¶ÇÇÑ Bill & Melinda Gates Foundation°ú °°Àº Á¶Á÷°ú ÆÄÆ®³Ê½ÊÀ» ¸Î°í Á¦ÇÑµÈ ÀÚ¿ø ȯ°æ¿¡¼­ HIV °Ë»ç¿¡ ´ëÇÑ Á¢±ÙÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ÃßÁ¤³â

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ºÐ¼®
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå ¹ÙÀÌ·¯½º °Ë»çÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ½ÃÀåÀÇ ¹Ì·¡ µ¿Çâ

Á¦4Àå ¹ÙÀÌ·¯½º °Ë»ç ¾÷°èÀÇ Á¶»ç

  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ±ÔÁ¦ Ʋ ºÐ¼®

Á¦5Àå ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

  • COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
  • COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®

Á¦6Àå ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå »óȲ

  • ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
  • ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ÀÇ ºÐ¼®
    • ½ÅÈï±â¾÷ÀÇ ºÐ¼®

Á¦7Àå ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå-À¯Çüº°

  • °³¿ä
    • À¯Çüº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ±â±â
    • ºÐ¼® ŰƮ
    • ¼Ò¸ðǰ

Á¦8Àå ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå-Áø´Üº°

  • °³¿ä
    • Áø´Üº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ºÐÀÚÁø´Ü¹ý
    • PCR¹ý
    • ¸é¿ª ÃøÁ¤¹ý
    • Áú·® ºÐ¼®¹ý
    • ±âŸ

Á¦9Àå ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå - ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä
    • ÃÖÁ¾ »ç¿ëÀÚº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • º´¿ø ¹× Ŭ¸®´Ð
    • Áø´Ü ½ÇÇè½Ç
    • ±âŸ

Á¦10Àå ¹ÙÀÌ·¯½º °Ë»ç ½ÃÀå-Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ¹ÙÀÌ·¯½º °Ë»ç ¾÷°è

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Abbott Laboratories
    • Roche Diagnostics
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories
    • Cepheid
    • Hologic, Inc.
    • Quidel Corporation
    • Siemens Healthineers
    • BD
    • bioMerieux
    • Qiagen
    • Meridian Bioscience, Inc.
    • Luminex Corporation
    • DiaSorin
    • Anitoa
    • ±âŸ

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

JHS 24.07.26

REPORT HIGHLIGHT

Virology Testing Market size was valued at USD 12,900.10 Million in 2023, expanding at a CAGR of 2.90% from 2024 to 2032.

Virology testing refers to a range of laboratory tests used to detect the presence of viruses or viral components in biological samples such as blood, saliva, or tissue. These tests are crucial for diagnosing viral infections, monitoring disease progression, and assessing the effectiveness of Diagnosis.

Virology Testing Market- Market Dynamics

Growing prevalence of viral infections and personalized medicines are expected to propel market demand

The frequency and spread of viral diseases drive the demand for virology testing. Outbreaks of diseases like influenza, HIV, hepatitis, and emerging viruses like Zika and Ebola contribute to the market growth. Growing awareness about viral diseases and the importance of early detection and Diagnosis encourages individuals to undergo screening tests. Public health initiatives, vaccination campaigns, and routine screening programs also fuel market demand. Modern virology testing methods, like point-of-care testing, PCR, and next-generation sequencing, improve sensitivity, specificity, and speed of diagnosis. Market expansion is further fueled by ongoing innovation in data analysis, automation, and assay development.

The need for molecular diagnostics, such as virology testing, is driven by the trend toward personalized medicine and precision healthcare, which aims to customize therapies based on unique viral and genetic profiles. A strong virology testing infrastructure is essential for the early diagnosis, surveillance, and containment of new infectious diseases, as demonstrated by events like the COVID-19 pandemic. To improve pandemic preparedness and response, governments and healthcare institutions place a high priority on investing in virology testing capabilities.

Virology Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.90% over the forecast period (2024-2032)

Based on Type segmentation, the instruments segment was predicted to show maximum market share in the year 2023, owing to its high demand for small instruments & related kits.

Based on Diagnosis segmentation, the PCR-based method segment was the leading Diagnosis in 2023, PCR methods are widely used for detecting viruses & pathogens.

Based on End User segmentation, the hospitals & clinics segment was the leading End User in 2023, owing to the high demand for virology testing at hospitals & clinics.

On the basis of region, North America was the leading revenue generator in 2023, owing to high spending on the healthcare industry.

Virology Testing Market- Segmentation Analysis:

The Global Virology Testing Market is segmented on the basis of Type, Diagnosis, End User, and Region.

The market is divided into three categories based on Type: instruments, assay kits, and consumables. The instruments segment dominates the market. High demands for antigen and viruses tests using instruments is promoting market growth.

The market is divided into five categories based on the diagnosis: PCR-based method, molecular diagnostics method, mass spectroscopy-based method, immunoassay-based method, and others. The PCR-based method segment dominates the market. The recent COVID-19 pandemic and respiratory diseases are increasing the need for PCR-based method segment demand.

The market is divided into three categories based on End Users: hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The diagnostic laboratories segment is expected to expand at the highest rate over the forecast period with advancement in technologies.

Virology Testing Market- Geographical Insights

Worldwide, the Virology Testing market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the global market. The United States dominates the virology testing landscape due to factors such as high healthcare expenditure, advanced healthcare infrastructure, and strong R&D capabilities. The Asia-Pacific region presents significant growth opportunities for the virology testing market, fueled by factors such as rising healthcare expenditure, increasing prevalence of viral diseases, and improving access to healthcare services. Key developments include the expansion of diagnostic testing facilities and adoption of rapid testing technologies.

Virology Testing Market- Competitive Landscape:

The virology testing market includes a mix of multinational and domestic firms, generic drug manufacturers, and technology drug development companies. Major players in the market engage in forming partnerships, mergers and acquisitions, and investing in research and development to innovate new testing technologies. For example, Abbott has developed molecular and antigen-based tests for viruses such as HIV, hepatitis, and influenza. Abbott has also entered partnerships with organizations like the Bill & Melinda Gates Foundation to expand access to HIV testing in resource-limited settings.

Recent Developments:

In June 2022, Anitoa, a United States startup company developed a portable PCR molecular assay for monkeypox virus detection.

In 2022, Quidel Corporation a provider of rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic announces antigen testing solutions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VIROLOGY TESTING MARKET KEY PLAYERS

  • Abbott Laboratories
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Cepheid
  • Hologic, Inc.
  • Quidel Corporation
  • Siemens Healthineers
  • BD
  • bioMerieux
  • Qiagen
  • Meridian Bioscience, Inc.
  • Luminex Corporation
  • DiaSorin
  • Anitoa
  • Others

GLOBAL VIROLOGY TESTING MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Instruments
  • Assay Kits
  • Consumables

GLOBAL VIROLOGY TESTING MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019-2032

  • Molecular Diagnostics Method
  • PCR-based method
  • Immunoassay-based method
  • Mass spectroscopy-based method
  • Others

GLOBAL VIROLOGY TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals & clinics
  • Diagnostic laboratories
  • Others

GLOBAL VIROLOGY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Virology Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Virology Testing Market Snippet by Type
    • 2.1.2. Virology Testing Market Snippet by Diagnosis
    • 2.1.3. Virology Testing Market Snippet by End User
    • 2.1.4. Virology Testing Market Snippet by Country
    • 2.1.5. Virology Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Virology Testing Key Market Trends

  • 3.1. Virology Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Virology Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Virology Testing Market Opportunities
  • 3.4. Virology Testing Market Future Trends

4. Virology Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Virology Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Virology Testing Market Landscape

  • 6.1. Virology Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Virology Testing Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Instruments
    • 7.1.3. Assay Kits
    • 7.1.4. Consumables

8. Virology Testing Market - By Diagnosis

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis, 2024 & 2032 (%)
    • 8.1.2. Molecular Diagnostics Method
    • 8.1.3. PCR-based method
    • 8.1.4. Immunoassay-based method
    • 8.1.5. Mass spectroscopy-based method
    • 8.1.6. Others

9. Virology Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals & clinics
    • 9.1.3. Diagnostic laboratories
    • 9.1.4. Others

10. Virology Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Virology Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Virology Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Virology Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Virology Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Virology Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Virology Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Roche Diagnostics
    • 11.2.3. Thermo Fisher Scientific
    • 11.2.4. Bio-Rad Laboratories
    • 11.2.5. Cepheid
    • 11.2.6. Hologic, Inc.
    • 11.2.7. Quidel Corporation
    • 11.2.8. Siemens Healthineers
    • 11.2.9. BD
    • 11.2.10. bioMerieux
    • 11.2.11. Qiagen
    • 11.2.12. Meridian Bioscience, Inc.
    • 11.2.13. Luminex Corporation
    • 11.2.14. DiaSorin
    • 11.2.15. Anitoa
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦